TL;DR
- A man in Oslo has achieved five years of HIV remission after a stem-cell transplant.
- The transplant came from his brother, who has a rare mutation linked to HIV resistance.
- Clinicians warn this approach is not widely applicable.
- Stem-cell transplants are high-risk and usually for severe conditions.
- Antiretroviral therapy remains the standard treatment for most HIV patients.
In a groundbreaking medical marvel, a 64-year-old man from Oslo has achieved an astonishing five years of HIV remission, thanks to a stem-cell transplant from his brother. This rare procedure, which has left many in the medical community buzzing, highlights both hope and caution in the ongoing battle against HIV.
The man, who was diagnosed with HIV back in 2006 at the age of 44, underwent this life-altering transplant to treat a separate bone marrow cancer. His brother, the donor, possesses a rare genetic mutation known as CCR5Δ32/Δ32, which has been linked to resistance against various strains of HIV. Talk about a double whammy of luck!
Published in the prestigious journal Nature Microbiology, the research reveals that two years post-transplant, tests showed no detectable HIV DNA in the man’s blood or gut tissues. In fact, an analysis of over 65 million immune system cells found no virus capable of replicating. As one of the study authors put it, “Replication-competent virus and HIV-specific T cell responses were absent.” This is the kind of news that makes you want to throw a pride parade!
However, before you start planning your celebrations, experts are quick to point out that this is not a feasible route to a widely available cure. The odds of finding a sibling with the CCR5 mutation are slim—only about 25% chance of a match for a transplant, and the mutation itself is present in just 1% of Northern European populations. So, while this case is a beacon of hope, it’s also a stark reminder of the rarity of such outcomes.
Stem-cell transplantation is a high-risk intervention, typically reserved for life-threatening conditions like blood cancers. For the majority of people living with HIV, antiretroviral therapy (ART) remains the gold standard, allowing them to live long, healthy lives with an undetectable viral load. The principle of U=U (Undetectable = Untransmittable) is a game-changer, especially for LGBTQ+ communities who have been at the forefront of HIV activism and public health messaging.
As study author Marius Trøseid aptly noted, the patient “feels like he has won the lottery twice.” Not only did he beat cancer, but he also appears to have beaten HIV. While we celebrate this incredible story, let’s keep pushing for more accessible treatments and cures for everyone living with HIV. After all, in the world of health and wellness, every victory counts, especially in our vibrant LGBTQ+ community.
https://twitter.com/share?text=https://www.thepinknews.com/2026/04/14/hiv-cure-oslo-2026/